MedTrace Logo

Study Comparing EBUS & EUS to Mediastinoscopy in Staging and Detection of Lung Cancer

NCT00970645 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2

Last updated 2011-07-18

No results posted yet for this study

Summary

This is a prospective randomized clinical trial with the study cohort comprised of all male and female patients over the age of 21 presenting to the study site for evaluation of lung cancer. The study will enroll 300 subjects, with 150 in each arm. Three sites will be in the study, Mayo Rochester, Mayo Jacksonville and Medical University of South Carolina. Mayo Rochester will enroll approximately 125 subjects. This study does not require subjects to undergo any additional procedures than what they would receive per standard medical care. The consenting subjects will receive EUS and /or EBUS- guided FNA or Mediastinoscopy/Thoracoscopy.

Conditions

  • Non Small Cell Lung Cancer

Interventions

PROCEDURE

Mediastinoscopy/thoracoscopy

Mediastinoscopy used to detect/stage lung cancer.

PROCEDURE

EBUS/EUS

Minimal invasive technique to stage/detect lung cancer.

Sponsors & Collaborators

  • Medical University of South Carolina

    collaborator OTHER

  • Mayo Clinic

    lead OTHER

Principal Investigators

  • Brenda Hoffman, M.D. · Medical University of South Carolina

  • Eric S Edell, M.D. · Mayo Clinic, Rochester, MN

  • Michael Wallace, M.D. · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-02-28
Primary Completion
2011-03-31
Completion
2011-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00970645 on ClinicalTrials.gov